Enanta Pharmaceuticals Inc (ENTA)
12.48
-0.44
(-3.41%)
USD |
NASDAQ |
Apr 25, 16:00
12.48
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Total Return Level: 12.92 for April 24, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 24, 2024 | 12.92 |
April 23, 2024 | 13.15 |
April 22, 2024 | 13.44 |
April 19, 2024 | 13.32 |
April 18, 2024 | 13.23 |
April 17, 2024 | 14.00 |
April 16, 2024 | 15.36 |
April 15, 2024 | 16.15 |
April 12, 2024 | 16.45 |
April 11, 2024 | 16.75 |
April 10, 2024 | 16.54 |
April 09, 2024 | 16.82 |
April 08, 2024 | 16.36 |
April 05, 2024 | 16.51 |
April 04, 2024 | 16.18 |
April 03, 2024 | 16.71 |
April 02, 2024 | 16.35 |
April 01, 2024 | 17.02 |
March 28, 2024 | 17.46 |
March 27, 2024 | 16.53 |
March 26, 2024 | 15.95 |
March 25, 2024 | 13.94 |
March 22, 2024 | 14.59 |
March 21, 2024 | 14.63 |
March 20, 2024 | 14.50 |
Date | Value |
---|---|
March 19, 2024 | 14.04 |
March 18, 2024 | 13.51 |
March 15, 2024 | 14.21 |
March 14, 2024 | 13.86 |
March 13, 2024 | 14.44 |
March 12, 2024 | 14.54 |
March 11, 2024 | 15.08 |
March 08, 2024 | 15.40 |
March 07, 2024 | 15.72 |
March 06, 2024 | 15.66 |
March 05, 2024 | 15.06 |
March 04, 2024 | 15.65 |
March 01, 2024 | 15.35 |
February 29, 2024 | 14.37 |
February 28, 2024 | 14.30 |
February 27, 2024 | 14.05 |
February 26, 2024 | 14.04 |
February 23, 2024 | 13.46 |
February 22, 2024 | 12.51 |
February 21, 2024 | 12.98 |
February 20, 2024 | 12.79 |
February 16, 2024 | 12.99 |
February 15, 2024 | 13.26 |
February 14, 2024 | 13.21 |
February 13, 2024 | 12.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
8.18
Minimum
Nov 13 2023
97.37
Maximum
Nov 05 2021
48.51
Average
49.70
Median
Total Return Level Benchmarks
Madrigal Pharmaceuticals Inc | 204.65 |
Galectin Therapeutics Inc | 3.29 |
Viking Therapeutics Inc | 65.07 |
Akero Therapeutics Inc | 20.26 |
89bio Inc | 8.58 |